Search - tctmd.com

Displaying 1 - 20 of 117

Sort: Relevancy | Date

News Conference News AHA 2025

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

Todd Neale

November 08, 2025

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News TCT 2021

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Michael O'Riordan

October 15, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

Shelley Wood

April 06, 2021

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Opinion CV Team Dispatch

January 2021 News Roundup

L.A. McKeown

January 01, 2021

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

Advertisement

One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

What’s Going to Be Hot at TCT 2025

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCTMD’s Top 10 Most Popular Stories for August 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

SCAAR Registry Delves Into Left Main Revascularization Outcomes

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

April 2021 News Roundup

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

January 2021 News Roundup

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content